Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other
companies in this sector in China:
Joincare Pharmaceutical Group Industry Company Limited
sales of 8.64 billion Chinese Renmimbi [US$1.28 billion]
of which 39%
was Chemical Agents),
Jiangsu Hengrui Medicine Co., Ltd.
(9.32 billion Chinese Renmimbi [US$1.38 billion]
of which 98%
was Medicinal Manufacturing), and
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(7.90 billion Chinese Renmimbi [US$1.17 billion]
of which 95%
Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 8.77 billion Chinese Renmimbi (US$1.30 billion)
December of 2015.
decrease of 13.2%
versus 2014, when the company's sales were 10.10 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 86.4% decline
in Other, Main Operations, from 2.67 million Chinese Renmimbi to 364,524.95 Chinese Renmimbi.
There were also decreases in sales in
Drug/medicine Sales (down 14.3% to 5.62 billion Chinese Renmimbi)
Medicinal Manufacturing (down 12.2% to 2.99 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Other Operations (up 21.7% to 155.17 million Chinese Renmimbi)